These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31668745)

  • 1. Periprocedural Dynamics of Aortic Regurgitation in Patients Supported With an Impella Left Ventricular Assist Device.
    Butala B; Yu R; Schorr R; Gologorsky E
    J Cardiothorac Vasc Anesth; 2020 Mar; 34(3):659-662. PubMed ID: 31668745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Severity of Aortic Regurgitation Due to a Percutaneous Left Ventricular Assist Device (Impella 5.0): A Retrospective Observational Study.
    Hotta N; Tsukinaga A; Yoshitani K; Fukushima S; Ohnishi Y
    J Cardiothorac Vasc Anesth; 2023 Jan; 37(1):23-30. PubMed ID: 36372720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment With Impella Increases the Risk of De Novo Aortic Insufficiency Post Left Ventricular Assist Device Implant.
    Rao SD; Johnson B; Olia SE; Wald J; Medina V; Rame JE; Mazurek JA; Goldberg LR; Atluri P; Bermudez C; Acker M; Birati EY
    J Card Fail; 2020 Oct; 26(10):870-875. PubMed ID: 32681883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Percutaneous Left Ventricular Assist Device Placement on Native Valve Competency.
    Hironaka CE; Ortoleva J; Zhan Y; Chen FY; Couper GS; Kapur NK; Kawabori M
    ASAIO J; 2022 Apr; 68(4):541-546. PubMed ID: 34419983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color Doppler Artifact Masking Iatrogenic Aortic Valve Injury Related to an Impella Device.
    Hong E; Naseem T
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1584-1587. PubMed ID: 30467028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
    McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Almalla M; Kersten A; Altiok E; Marx N; Schröder JW
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):357-362. PubMed ID: 31268621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outflow graft anastomosis site design could be correlated to aortic valve regurgitation under left ventricular assist device support.
    Iizuka K; Nishinaka T; Ichihara Y; Miyamoto T; Yamazaki K
    J Artif Organs; 2018 Jun; 21(2):150-155. PubMed ID: 29164425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
    Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation?†.
    Patil NP; Mohite PN; Sabashnikov A; Dhar D; Weymann A; Zeriouh M; Koch A; Garcia-Saez D; Zych B; Hards R; Hedger M; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Popov AF; Banner N; Simon AR
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):788-94. PubMed ID: 26108216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfemoral aortic valve replacement for severe aortic valve regurgitation in a patient with a pulsatile-flow biventricular assist device.
    Gomes B; Bekeredjian R; Leuschner F; Ehlermann P; Schmack B; Ruhparwar A; Raake PW; Katus HA; Kreusser MM
    ESC Heart Fail; 2019 Feb; 6(1):217-221. PubMed ID: 30479049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the Development of Aortic Regurgitation After Impella Left Ventricular Assist Device Support.
    Imamura T
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2550-2551. PubMed ID: 32475779
    [No Abstract]   [Full Text] [Related]  

  • 15. Rescue TAVI for Aortic Regurgitation after Left Ventricular Assist Device Implantation Following Preoperative Impella® Support.
    M Herrmann FE; Wellmann P; von Dossow V; Massberg S; Hagl C; Schramm R; Pichlmaier M
    J Heart Valve Dis; 2017 Sep; 26(5):603-605. PubMed ID: 29762934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo aortic regurgitation after continuous-flow left ventricular assist device implantation.
    Patil NP; Sabashnikov A; Mohite PN; Garcia D; Weymann A; Zych B; Bowles CT; Hards R; Hedger M; Popov AF; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Banner NR; Simon AR
    Ann Thorac Surg; 2014 Sep; 98(3):850-7. PubMed ID: 25069685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prognosis of vascular complications after percutaneous placement of left ventricular assist device.
    Abaunza M; Kabbani LS; Nypaver T; Greenbaum A; Balraj P; Qureshi S; Alqarqaz MA; Shepard AD
    J Vasc Surg; 2015 Aug; 62(2):417-23. PubMed ID: 26054591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
    Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device.
    Anderson M; Morris DL; Tang D; Batsides G; Kirtane A; Hanson I; Meraj P; Kapur NK; O'Neill W
    J Heart Lung Transplant; 2018 Dec; 37(12):1448-1458. PubMed ID: 30241890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Impella RP use for refractory right heart failure in adolescents and young adults-A multicenter U.S. experience.
    Qureshi AM; Turner ME; O'Neill W; Denfield SW; Aghili N; Badiye A; Gandhi R; Tehrani B; Chang G; Oyama JK; Sinha S; Brozzi N; Morray B
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):376-381. PubMed ID: 32129576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.